Regent Peak Wealth Advisors LLC Exact Sciences Corp Transaction History

Regent Peak Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$56.27 - $73.77 $56 - $73	1 Added 0.02%	5,820 $401,000
Q4 2023 Jan 23, 2024	BUY	$59.06 - $75.72 $590 - $757	10 Added 0.17%	5,819 $430,000
Q2 2023 Jul 19, 2023	SELL	$62.68 - $95.05 $290,584 - $440,651	-4,636 Reduced 44.38%	5,809 $545,000
Q1 2023 Apr 24, 2023	SELL	$47.19 - $70.77 $54,693 - $82,022	-1,159 Reduced 9.99%	10,445 $708,000
Q4 2022 Feb 08, 2023	SELL	$30.35 - $53.15 $17,542 - $30,720	-578 Reduced 4.74%	11,604 $574,000
Q2 2022 Aug 11, 2022	BUY	$35.61 - $76.23 $433,801 - $928,633	12,182 New	12,182 $479,000
Q1 2021 Apr 28, 2021	SELL	$116.57 - $155.01 $4,196 - $5,580	-36 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $3,585 - $5,116	36 New	36 $5,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.